File(s) under permanent embargo
The chromosome 21 transcription factor ETS2 transactivates the β-APP promoter: implications for Down syndrome
journal contributionposted on 2003-07-28, 00:00 authored by E W Wolvetang, O M Bradfield, M Tymms, Silva ZavarsekSilva Zavarsek, T Hatzistavrou, I Kola, P J Hertzog
The gene that codes for beta-amyloid precursor protein (beta-APP), a protein centrally involved in senile plaque formation in Down syndrome (DS) and Alzheimer's disease (AD), is located on chromosome 21. In DS beta-APP expression is three- to fourfold higher than what is expected from the 1.5-fold increased gene load, suggesting that other genes on chromosome 21 directly or indirectly can further up-regulate beta-APP. Here we show that the chromosome 21 transcription factor ETS2 transactivates the beta-APP gene via specific Ets binding sites in the beta-APP promoter and, in this respect, cooperates with the transcription factor complex AP1. We further show that brains and primary neuronal cultures from Ets2 transgenic mice, as well as 3T3 fibroblasts that overexpress ETS2, display molecular abnormalities also seen in DS, such as elevated expression of beta-APP protein, an increase in presenilin-1 and increased beta-amyloid production. We conclude that ETS2 is a transcriptional regulator of beta-APP and that overexpression of ETS2 in DS may play a role in the pathogenesis of the brain abnormalities in DS and possibly AD.
JournalBiochimica et Biophysica Acta (BBA) - gene structure and expression
Pagination105 - 110
LocationAmsterdam, The Netherlands
Publication classificationC1.1 Refereed article in a scholarly journal
Copyright notice2003, Elsevier B.V.
CategoriesNo categories selected
ETS2β-APPAP1Promoter regulationDown syndromeScience & TechnologyLife Sciences & BiomedicineBiochemistry & Molecular BiologyBiophysicsbeta-APPAMYLOID PRECURSOR PROTEINHUMAN NEUROBLASTOMA-CELLSHUMAN PRESENILIN-1 GENEALZHEIMERS-DISEASEOXIDATIVE STRESSA-BETAPLAQUE-FORMATIONTRANSGENIC MICESENILE PLAQUESDNA-BINDING